AzTrials
AzTrials

Cerebral PalsyGIFTNCT04794114

enGIneering For sporT for All

A study testing experimental ankle foot orthosis and traditional ankle foot orthosis in people with Cerebral Palsy, run by IRCCS Eugenio Medea at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

hemiplegia is a pathological condition that affects one side of the body which is associated with difficulty in maintaining an upright posture and walking and which is commonly compensated for by using orthoses (AFO). Read more about this study

Who is it for?
Ages 6 to 11 years
Conditions the study is for
Cerebral Palsy
What is being tested?
experimental ankle foot orthosis and traditional ankle foot orthosis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteItaly
Study dates
1 Sep 2020to 30 Nov 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 11 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Users of Ankle Foot Orthosis (AFO) without any time limit;
  • GMFCS 1-2 scale values;
  • Ashworth triceps sural values <= 3.

Who cannot join

  • patients using knee and hip orthoses (KAFO, HKAFO);
  • patients who need assisted walking (use of crutches, walkers or other);
  • uncooperative patients.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS E. Medea

    Bosisio Parini, LC, 23842

Other trials in Italy

About this study

hemiplegia is a pathological condition that affects one side of the body which is associated with difficulty in maintaining an upright posture and walking and which is commonly compensated for by using orthoses (AFO). However, the orthoses are inadequate for sports from a design and prescription point of view, which specifies that the goal of the orthosis is to support walking and that any other use compromises its reliability.

The main objective therefore provides for an improvement in the involvement of these children in sports activities (both at school and during leisure time) through the development of new generation orthoses.

Read the detailed description

The main objective therefore provides for an improvement in the involvement of these children in sports activities (both at school and during leisure time) through the development of new generation orthoses.

Secondary objective: the second objective involves the verification of the orthosis previously designed and built, ie the device must comply with the project specifications and allow the patient to perform sports activities. Correct functioning will be tested by functional evaluation of the model developed through biomechanical analysis of movement performed indoors (in the laboratory) and outdoors.

Notes on the calculation of the sample size: the project foresees the involvement at the moment of 20 children with hemiplegia under treatment at MEDEA to whom an overall improvement of the living conditions is to be guaranteed.

Steps: 1-Technology design - "to play together" 2 - Analysis and identification of the guidelines for the prescription of use; 3 - Evaluation of the motor biomechanical situation of subjects wearing orthoses: indoor and outdoor to evaluate the limits of the orthosis used; 4 - identification of indicators for the evaluation of motor performance; 5 - Identification of the technical specifications (functional and clinical, mechanical, structural, geometric, materials, design) of the new generation orthosis-sensor system.

6- Definition of inclusion criteria, recruitment of 20 subjects starting from Medea and contacts with schools and families to which they belong.

7- Validation- "to verify it really runs" WP5.1 - Functional evaluation of the model developed through biomechanical analysis of movement carried out in the laboratory.

The I.R.C.C.S E. Medea will appropriately select 20 children with hemiplegia and wearers of orthoses.

A biomechanical assessment will be performed through gait analysis to identify the limits of the orthosis used.

8- Two conditions will be evaluated:

  • walking tests without orthoses;
  • walking tests with orthoses usually used. From the comparative analysis of the collected data, the criticalities of the device will be defined in order to identify the project specifications of the new generation orthosis. 9-Following the design and construction of the new AFO, a biomechanical evaluation will be performed again by means of gait analysis to validate its correct functioning. 10- Further validation will be performed using virtual reality environments (GRAIL Gait Real time Analysis Interactive Lab).

After a rehabilitation process, once a certain degree of confidence has been reached in the use of the new orthosis, the device will be tested using outdoor wearable sensors. By doing so, it will be possible to identify indicators for the evaluation of sports performance.

Conditions
Cerebral Palsy
Being tested
experimental ankle foot orthosis, traditional ankle foot orthosis
Keywords
orthosis, hemiplegia
Medical subject headings
Cerebral Palsy, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • experimental ankle foot orthosisDevice

    On the basis of an accurate kinetic and kinematic analysis, a customized orthosis in thermoplastic material with carbon inserts will be created that will make the brace more elastic and facilitate the child's motor activities.

  • traditional ankle foot orthosisDevice

    The normal afos in thermoplastic material, while guaranteeing an ankle joint stability, make the joint more rigid and reduce the elasticity of movement especially during running, jumping and sprinting.

Study groups in NCT04794114
Study groupRoleWhat they receive
orthosis in hemiplegiaExperimentalNot described
Receives: Device: experimental ankle foot orthosis; Device: traditional ankle foot orthosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. gait analysis with standard ankle foot orthosis

    kinematic (joint angle during gait cycle) and kinetic evaluation (power generation and absorption and moments) both with standard orthosis

    Measured: The evaluations are performed before the new ankle foot orthosis is delivered

  2. gait analysis with experimental ankle foot orthosis

    kinematic (joint angle during gait cycle) and kinetic evaluation (power generation and absorption and moments) both with experimental orthosis

    Measured: The evaluations are performed 1 month after the new ankle foot orthosis is delivered

Secondary outcomes (2)
  1. G- sensor with standard ankle foot orthosis

    accelerometric evaluation during running and sprinting (linar parameters, velocity, step length, cadency) with standard orthosis

    Measured: The evaluations are performed before the new ankle foot orthosis is delivered

  2. G- sensor with experimental ankle foot orthosis

    accelerometric evaluation during running and sprinting (linar parameters, velocity, step length, cadency) with experimental orthosis

    Measured: The evaluation is performed 1 month after the new ankle foot orthosis is delivered

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2021
  2. Study start1 Sep 2020
  3. Primary completion30 Nov 2021
  4. Study completion30 Nov 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Sequential
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04794114
Sponsor's protocol ID
713
Acronym
GIFT
Status last verified
Apr 2025
First submitted
11 Feb 2021
Last updated
1 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing experimental ankle foot orthosis and traditional ankle foot orthosis in people with Cerebral Palsy, run by IRCCS Eugenio Medea at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

gait analysis with standard ankle foot orthosis (time frame: The evaluations are performed before the new ankle foot orthosis is delivered). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in